المؤلفون: Manuel Francisco Ugarte-Gil, John Hanly, Murray Urowitz, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sanchez-Guerrero, Sasha Bernatsky, Ann Elaine Clarke, Daniel J Wallace, David Alan Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N Bruce, Michelle Petri, Ellen M Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jönsen, Ronald F van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, Sam Lim, Murat Inanc, Ken Kalunian, Søren Jacobsen, Christine Peschken, Diane L Kamen, Anca Askanase, Bernardo A Pons-Estel, Graciela S Alarcón

المساهمون: Rheumatology, AII - Inflammatory diseases, Clinical Immunology and Rheumatology, AMS - Musculoskeletal Health

المصدر: Ugarte-Gil, M F, Hanly, J, Urowitz, M, Gordon, C, Bae, S-C, Romero-Diaz, J, Sanchez-Guerrero, J, Bernatsky, S, Clarke, A E, Wallace, D J, Isenberg, D A, Rahman, A, Merrill, J T, Fortin, P R, Gladman, D D, Bruce, I N, Petri, M, Ginzler, E M, Dooley, M A, Ramsey-Goldman, R, Manzi, S, Jönsen, A, van Vollenhoven, R F, Aranow, C, MacKay, M, Ruiz-Irastorza, G, Lim, S, Inanc, M, Kalunian, K, Jacobsen, S R, Peschken, C, Kamen, D L, Askanase, A, Pons-Estel, B A & Alarcón, G S 2022, ' Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus : Results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort ', Annals of the Rheumatic Diseases, vol. 81, no. 11, 222487, pp. 1541-1548 . https://doi.org/10.1136/ard-2022-222487
Annals of the Rheumatic Diseases, 81(11):222487, 1541-1548. BMJ Publishing Group
Annals of the rheumatic diseases, 81(11):222487, 1541-1548. BMJ Publishing Group

مصطلحات موضوعية: Male, Immunology, Remission Induction, outcome assessment, health care, health care, Severity of Illness Index, General Biochemistry, Genetics and Molecular Biology, Antimalarials, low disease activity, systemic lupus erythematosus, Rheumatology, Systemic Lupus International Collaborating Clinics, Disease Progression, Immunology and Allergy, Humans, Lupus Erythematosus, Systemic, Prednisone, epidemiology, Female, outcome assessment, Immunosuppressive Agents

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c46b04ea63f72c1e61fa1207c98bfe3
https://pubmed.ncbi.nlm.nih.gov/36008131

المؤلفون: Daniel J. Wallace, Vibeke Strand, Frédéric Houssiau, B. Kilgallen, Michelle Petri, Caroline Gordon, Lexy Kelley, Marilyn C. Pike, Kenneth C. Kalunian, S. Bongardt, Anna Barry

المساهمون: UCL - SSS/IREC/RUMA - Pôle de Pathologies rhumatismales, UCL - (SLuc) Service de rhumatologie

المصدر: Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, Vol. 73, no. 1, p. 183-190 (2013)

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Immunology, Treatment outcome, Placebo, Antibodies, Monoclonal, Humanized, Severity of Illness Index, Systemic Lupus Erythematosus, General Biochemistry, Genetics and Molecular Biology, Double blind, Placebos, Rheumatology, Double-Blind Method, immune system diseases, Internal medicine, Severity of illness, medicine, Immunology and Allergy, Humans, Lupus Erythematosus, Systemic, In patient, skin and connective tissue diseases, B-Lymphocytes, B cells, business.industry, Dosing regimen, Middle Aged, Clinical and Epidemiological Research, medicine.disease, Connective tissue disease, 3. Good health, Surgery, Treatment, Treatment Outcome, Female, business, Epratuzumab, Immunosuppressive Agents, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c41350b368609a2618146fd1a58509b
https://pubmed.ncbi.nlm.nih.gov/23313811

المؤلفون: Søren Jacobsen, Caroline Gordon, Diane L. Kamen, Lene Dreyer, Juanita Romero-Diaz, Ola Nived, Edward H. Yelin, Sang Cheol Bae, Rosalind Ramsey-Goldman, Guillermo Ruiz-Irastorza, Susan G. Barr, Anca Askanase, Irene Blanco, Yvan St. Pierre, Dafna D. Gladman, Neha M. Patel, J. F. Boivin, Christine A. Peschken, Ellen M. Ginzler, Lawrence Joseph, Michelle Petri, Lindsey A. Criswell, Steven M. Edworthy, Anisur Rahman, David A. Isenberg, Mary Anne Dooley, Ann E. Clarke, Susan Manzi, Gunnar Sturfelt, Karen H. Costenbader, Paul R. Fortin, Murray B. Urowitz, Daniel J. Wallace, Torsten Witte, Cynthia Aranow, Sasha Bernatsky, Candace H. Feldman

المصدر: Annals of the rheumatic diseases, vol 73, iss 1

مصطلحات موضوعية: Oncology, Male, Lymphoma, Epidemiology, Azathioprine, immune system diseases, Risk Factors, hemic and lymphatic diseases, Immunology and Allergy, Lupus Erythematosus, Systemic, Young adult, skin and connective tissue diseases, Cancer, education.field_of_study, Lymphoma, Non-Hodgkin, Hematology, Middle Aged, Connective tissue disease, Hodgkin Disease, Rheumatoid arthritis, 6.1 Pharmaceuticals, Public Health and Health Services, Female, Immunosuppressive Agents, medicine.drug, Adult, medicine.medical_specialty, Cyclophosphamide, Population, Clinical Sciences, Immunology, Non-Hodgkin, Lupus, Systemic Lupus Erythematosus, Autoimmune Disease, General Biochemistry, Genetics and Molecular Biology, Article, Antimalarials, Young Adult, Rare Diseases, Rheumatology, Clinical Research, Internal medicine, medicine, Humans, education, Disease Activity, Glucocorticoids, Lupus Erythematosus, business.industry, Prevention, Inflammatory and immune system, Systemic, Case-control study, Evaluation of treatments and therapeutic interventions, Mycophenolic Acid, medicine.disease, Arthritis & Rheumatology, Treatment, Good Health and Well Being, Methotrexate, Case-Control Studies, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f456334de0a84ed09dcdc4339a63706
https://pubmed.ncbi.nlm.nih.gov/23303389

المؤلفون: Barbara White, Gabriel Robbie, Bahija Jallal, Daniel J. Wallace, Chenxiong Le, Nancy J. Olsen, Michelle Petri, Kyriakos A. Kirou, Wendy I. White, Laura Richman, Yihong Yao, Robert Levin, Seth Mark Berney, Joan T. Merrill, Vishala Chindalore

المصدر: Annals of the rheumatic diseases. 70(11)

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Immunology, Placebo, Antibodies, Monoclonal, Humanized, Gastroenterology, Severity of Illness Index, General Biochemistry, Genetics and Molecular Biology, Young Adult, Rheumatology, Double-Blind Method, Internal medicine, Immunopathology, medicine, Immunology and Allergy, Humans, Lupus Erythematosus, Systemic, RNA, Messenger, Adverse effect, Interferon alfa, Aged, Aged, 80 and over, Lupus erythematosus, Dose-Response Relationship, Drug, business.industry, Antibodies, Monoclonal, Interferon-alpha, Middle Aged, medicine.disease, Connective tissue disease, Treatment Outcome, Gene Expression Regulation, Pharmacodynamics, Injections, Intravenous, Interferon Type I, Female, Sifalimumab, business, Immunosuppressive Agents, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3420ba2b5b00be49820d5c32019d4899
https://pubmed.ncbi.nlm.nih.gov/21798883